BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22810449)

  • 1. The dangers of stopping a trial too early.
    Briel M; Bassler D; Wang AT; Guyatt GH; Montori VM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():56-60. PubMed ID: 22810449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trials stopped early for benefit: a systematic review.
    Montori VM; Devereaux PJ; Adhikari NK; Burns KE; Eggert CH; Briel M; Lacchetti C; Leung TW; Darling E; Bryant DM; Bucher HC; Schünemann HJ; Meade MO; Cook DJ; Erwin PJ; Sood A; Sood R; Lo B; Thompson CA; Zhou Q; Mills E; Guyatt GH
    JAMA; 2005 Nov; 294(17):2203-9. PubMed ID: 16264162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early stopping rules in oncology: considerations for clinicians.
    Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR
    Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trials stopped early for harm in HIV/AIDS: a systematic survey.
    Mills E; Cooper C; Wu P; Rachlis B; Singh S; Guyatt GH
    HIV Clin Trials; 2006; 7(1):24-33. PubMed ID: 16684642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous safety monitoring for randomized controlled clinical trials with blinded treatment information. Part 1: Ethical considerations.
    Ball G; Piller LB; Silverman MH
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S2-4. PubMed ID: 21664987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Data monitoring committees, interim analysis and early termination in paediatric trials.
    Fernandes RM; van der Lee JH; Offringa M
    Acta Paediatr; 2011 Oct; 100(10):1386-92. PubMed ID: 21434998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules.
    Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M;
    J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised trials with provision for early stopping for benefit (or harm): The impact on the estimated treatment effect.
    Walter SD; Guyatt GH; Bassler D; Briel M; Ramsay T; Han HD
    Stat Med; 2019 Jun; 38(14):2524-2543. PubMed ID: 30887553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trials addressing a similar question are commonly published after a trial stopped early for benefit.
    Murad MH; Guyatt GH; Domecq JP; Vernooij RWM; Erwin PJ; Meerpohl JJ; Prutsky GJ; Akl EA; Mueller K; Bassler D; Schandelmaier S; Walter SD; Busse JW; Kasenda B; Pagano G; Pardo-Hernandez H; Montori VM; Wang Z; Briel M
    J Clin Epidemiol; 2017 Feb; 82():12-19. PubMed ID: 27832953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stopping a trial early - and then what?
    Wittes J
    Clin Trials; 2012 Dec; 9(6):714-20. PubMed ID: 22879573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.
    Korn EL; Freidlin B
    Am J Bioeth; 2011 Mar; 11(3):2-10. PubMed ID: 21400374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early stopping of randomized clinical trials for overt efficacy is problematic.
    Bassler D; Montori VM; Briel M; Glasziou P; Guyatt G
    J Clin Epidemiol; 2008 Mar; 61(3):241-6. PubMed ID: 18226746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early termination of clinical trials: causes, consequences, and control. With special reference to trials in the field of arrhythmias and sudden death. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1994 Jun; 15(6):721-38. PubMed ID: 8088260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive Bayesian randomized trials: realizing their potential.
    Pullenayegum EM
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():29-33. PubMed ID: 22810444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2).
    Briel M; Lane M; Montori VM; Bassler D; Glasziou P; Malaga G; Akl EA; Ferreira-Gonzalez I; Alonso-Coello P; Urrutia G; Kunz R; Culebro CR; da Silva SA; Flynn DN; Elamin MB; Strahm B; Murad MH; Djulbegovic B; Adhikari NK; Mills EJ; Gwadry-Sridhar F; Kirpalani H; Soares HP; Abu Elnour NO; You JJ; Karanicolas PJ; Bucher HC; Lampropulos JF; Nordmann AJ; Burns KE; Mulla SM; Raatz H; Sood A; Kaur J; Bankhead CR; Mullan RJ; Nerenberg KA; Vandvik PO; Coto-Yglesias F; Schünemann H; Tuche F; Chrispim PP; Cook DJ; Lutz K; Ribic CM; Vale N; Erwin PJ; Perera R; Zhou Q; Heels-Ansdell D; Ramsay T; Walter SD; Guyatt GH
    Trials; 2009 Jul; 10():49. PubMed ID: 19580665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic survey of randomised trials that stopped early for reasons of futility.
    Walter SD; Han H; Guyatt GH; Bassler D; Bhatnagar N; Gloy V; Schandelmaier S; Briel M
    BMC Med Res Methodol; 2020 Jan; 20(1):10. PubMed ID: 31948397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.
    Wang H; Rosner GL; Goodman SN
    Clin Trials; 2016 Dec; 13(6):621-631. PubMed ID: 27271682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopping clinical trials early for benefit: impact on estimation.
    Freidlin B; Korn EL
    Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility.
    Walter SD; Han H; Briel M; Guyatt GH
    Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation and continuation of randomized trials after the publication of a trial stopped early for benefit asking the same study question: STOPIT-3 study design.
    Prutsky GJ; Domecq JP; Erwin PJ; Briel M; Montori VM; Akl EA; Meerpohl JJ; Bassler D; Schandelmaier S; Walter SD; Zhou Q; Coello PA; Moja L; Walter M; Thorlund K; Glasziou P; Kunz R; Ferreira-Gonzalez I; Busse J; Sun X; Kristiansen A; Kasenda B; Qasim-Agha O; Pagano G; Pardo-Hernandez H; Urrutia G; Murad MH; Guyatt G
    Trials; 2013 Oct; 14():335. PubMed ID: 24131702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.